Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea
Zom RL 1 , van Baal J, Goselink RM, Bakker JA, de Veth MJ, van Vuuren AM
Rhythm Pharmaceuticals (RYTM) is also involved in peptidergic drugs for weight loss
2014;5(4):e1172
US$ 23.34
US$ 21.02
US$ 29.50
US$ 29.70
